Skip to content

Suprachoroidal Hemorrhage Associated With Pars Plana Vitrectomy

Suprachoroidal Hemorrhage Associated With Pars Plana Vitrectomy

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05013281
Enrollment
28
Registered
2021-08-19
Start date
2010-01-01
Completion date
2021-01-28
Last updated
2021-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pars Plana Vitrectomy, Suprachoroidal Hemorrhage (Diagnosis)

Brief summary

To analyze the characteristics, related risk factors, and prognosis of suprachoroidal hemorrhage (SCH) associated with pars plana vitrectomy (PPV).

Interventions

PROCEDURESuprachoroidal hemorrhage associated with pars plana vitrectomy

SCH has a higher incidence rate after a second intraocular surgery in a vitrectomized eye which is associated with the lack of vitreous support and easier fluctuation of intraocular pressure. SCH associated with PPV is more localized and has a relatively good prognosis; high myopia and aphakic/ pseudophakic eyes are risk factors. Active treatment can effectively improve visual prognosis.

Sponsors

Beijing Tongren Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Suprachoroidal hemorrhage associated with pars plana vitrectomy

Exclusion criteria

* Patients with eye trauma-related Suprachoroidal hemorrhage were excluded.

Design outcomes

Primary

MeasureTime frameDescription
pathogenesisbaselinepathogenesis of PPV-related SCH and incidence of PPV-related SCH

Secondary

MeasureTime frameDescription
vision acuityup to 7 weeksthe final vision acuity

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026